🔹 In Tech news this week… SoftBank and Oracle forge strategic alliance to advance Japan’s AI and sovereign…
Eisai Co., Ltd. and Biogen Inc. LEQEMBI® IQLIK™ (lecanemab-irmb) is now available in the U.S. It’s a subcutaneous…
Eisai Co., Ltd. and Biogen Inc. have started a rolling supplemental Biologics License Application (sBLA) with the U.S.…
Eisai Co., Ltd. and Biogen Inc. shared that LEQEMBI (lecanemab), an anti-amyloid beta monoclonal antibody, launched in Austria…
Sign in to your account